Published in Ann Intern Med on February 03, 2004
Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol (2009) 4.16
Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study. Lancet (2009) 2.73
Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev (2009) 2.65
Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol (2011) 2.46
Microalbuminuria in HIV infection. AIDS (2007) 2.28
Insulin resistance in children with primary nephrotic syndrome and normal renal function. Pediatr Nephrol (2012) 2.03
Kidney pathological changes in metabolic syndrome: a cross-sectional study. Am J Kidney Dis (2009) 1.74
The conundrum of hyperuricemia, metabolic syndrome, and renal disease. Intern Emerg Med (2008) 1.65
Systemic inflammation, metabolic syndrome and progressive renal disease. Nephrol Dial Transplant (2009) 1.63
Metabolic syndrome, ESRD, and death in CKD. Clin J Am Soc Nephrol (2013) 1.63
Central body fat distribution associates with unfavorable renal hemodynamics independent of body mass index. J Am Soc Nephrol (2013) 1.62
Chronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study). Am J Cardiol (2008) 1.56
Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study. J Am Soc Nephrol (2006) 1.56
Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC). Am Heart J (2010) 1.55
Heart rate variability predicts ESRD and CKD-related hospitalization. J Am Soc Nephrol (2010) 1.46
Serum resistin and glomerular filtration rate in patients with type 2 diabetes. PLoS One (2015) 1.41
Physical activity and rapid decline in kidney function among older adults. Arch Intern Med (2009) 1.40
The Role of Overweight and Obesity in the Cardiorenal Syndrome. Cardiorenal Med (2011) 1.35
Dietary fructose causes tubulointerstitial injury in the normal rat kidney. Am J Physiol Renal Physiol (2010) 1.34
Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry. Diabetes Care (2008) 1.32
Evidence-based practice guideline for the treatment of CKD. Clin Exp Nephrol (2009) 1.29
Prehypertension: epidemiology, consequences and treatment. Nat Rev Nephrol (2009) 1.28
High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant (2008) 1.27
Insulin signaling regulating genes: effect on T2DM and cardiovascular risk. Nat Rev Endocrinol (2009) 1.19
The emerging epidemic of obesity, diabetes, and the metabolic syndrome in china. Cardiol Res Pract (2011) 1.19
Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications. J Transl Med (2011) 1.18
Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet. J Pharmacol Exp Ther (2010) 1.12
High-fat diet induces an initial adaptation of mitochondrial bioenergetics in the kidney despite evident oxidative stress and mitochondrial ROS production. Am J Physiol Endocrinol Metab (2011) 1.10
Blood pressure, atherosclerosis, and albuminuria in 10,113 participants in the atherosclerosis risk in communities study. J Hypertens (2009) 1.10
One-hour postload plasma glucose levels are associated with kidney dysfunction. Clin J Am Soc Nephrol (2010) 1.08
Prevalence of and factors associated with albuminuria in the Korean adult population: the 2011 Korea National Health and Nutrition Examination Survey. PLoS One (2013) 1.08
Aldosterone and glomerular podocyte injury. Clin Exp Nephrol (2008) 1.07
Lipoprotein abnormalities associated with mild impairment of kidney function in the multi-ethnic study of atherosclerosis. Clin J Am Soc Nephrol (2007) 1.07
Nondiabetic consequences of obesity on kidney. Pediatr Nephrol (2006) 1.07
Chronic kidney disease in United States Hispanics: a growing public health problem. Ethn Dis (2009) 1.06
The effects of highly active antiretroviral therapy on albuminuria in HIV-infected persons: results from a randomized trial. Nephrol Dial Transplant (2005) 1.06
Metabolic syndrome in a metapopulation of Croatian island isolates. Croat Med J (2006) 1.06
Metabolic syndrome, components, and cardiovascular disease prevalence in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Nephrol (2011) 1.05
The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: evidence for interaction with obesity in diabetic patients. Diabetes (2011) 1.05
The mammalian tribbles homolog TRIB3, glucose homeostasis, and cardiovascular diseases. Endocr Rev (2012) 1.04
Metabolic syndrome in a Taiwanese metropolitan adult population. BMC Public Health (2007) 1.03
Obesity management in adults with CKD. Am J Kidney Dis (2009) 1.02
Mineralocorticoid receptor antagonists and the metabolic syndrome. Curr Hypertens Rep (2010) 1.01
Therapeutic strategies to slow chronic kidney disease progression. Pediatr Nephrol (2008) 0.99
Circulating transforming growth factor-beta1 levels and the risk for kidney disease in African Americans. Kidney Int (2009) 0.98
Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort. Clin J Am Soc Nephrol (2010) 0.98
Obesity in CKD--what should nephrologists know? J Am Soc Nephrol (2013) 0.98
The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome. Curr Hypertens Rep (2012) 0.97
Obesity and diabetic kidney disease. Med Clin North Am (2012) 0.97
Impact of treating the metabolic syndrome on chronic kidney disease. Nat Rev Nephrol (2009) 0.96
Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines. Cardiol Res Pract (2011) 0.96
Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome. Cardiorenal Med (2013) 0.95
Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study. Diabetologia (2009) 0.95
Development and reproducibility of a computed tomography-based measurement of renal sinus fat. BMC Nephrol (2011) 0.95
Adiponectin action: a combination of endocrine and autocrine/paracrine effects. Front Endocrinol (Lausanne) (2011) 0.95
The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats. J Cell Mol Med (2010) 0.95
Obesity, metabolic health, and the risk of end-stage renal disease. Kidney Int (2014) 0.95
Body mass index is associated with increased creatinine clearance by a mechanism independent of body fat distribution. J Clin Endocrinol Metab (2009) 0.94
Relationship between body mass index and proteinuria in hypertensive nephrosclerosis: results from the African American Study of Kidney Disease and Hypertension (AASK) cohort. Am J Kidney Dis (2010) 0.94
Obesity and kidney protection. J Nephropathol (2014) 0.93
Association between Serum Uric Acid Level and Metabolic Syndrome and Its Sex Difference in a Chinese Community Elderly Population. Int J Endocrinol (2014) 0.93
Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney disease. J Lipid Res (2010) 0.92
Insulin and its role in chronic kidney disease. Pediatr Nephrol (2007) 0.91
Perfluoroalkyl chemicals and chronic kidney disease in US adults. Am J Epidemiol (2011) 0.91
Association between serum uric acid and the metabolic syndrome among a middle- and old-age Chinese population. Eur J Epidemiol (2013) 0.90
Long term metabolic syndrome induced by a high fat high fructose diet leads to minimal renal injury in C57BL/6 mice. PLoS One (2013) 0.90
Lipotoxicity and cardiac dysfunction in mammals and Drosophila. Crit Rev Biochem Mol Biol (2011) 0.90
Hyperuricemia and metabolic syndrome: associations with chronic kidney disease. Clin Rheumatol (2010) 0.89
Comorbidities and Metabolic Derangement of NAFLD. J Lifestyle Med (2015) 0.89
Physical Activity in the Prevention of Chronic Kidney Disease. Cardiorenal Med (2011) 0.87
Metabolic syndrome in rheumatoid arthritis. Mediators Inflamm (2013) 0.87
The pathophysiology of obesity and its clinical manifestations. Gastroenterol Hepatol (N Y) (2007) 0.87
Metabolic syndrome and chronic kidney disease: Current status and future directions. World J Nephrol (2014) 0.87
Metabolic syndrome, C-reactive protein, and mortality in U.S. Blacks and Whites: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Diabetes Care (2014) 0.87
Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome. Clin Exp Nephrol (2010) 0.87
Association between body mass index and chronic kidney disease: a population-based, cross-sectional study of a Japanese community. Vasc Health Risk Manag (2009) 0.87
A comparison of different approaches to unravel the latent structure within metabolic syndrome. PLoS One (2012) 0.87
Heart rate as a risk factor for developing chronic kidney disease: longitudinal analysis of a screened cohort. Clin Exp Nephrol (2009) 0.86
Metabolic syndrome and chronic kidney disease in an adult Korean population: results from the Korean National Health Screening. PLoS One (2014) 0.86
Non-Alcoholic Fatty Liver Disease Is a Risk Factor for the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus. PLoS One (2015) 0.86
Chronic kidney disease increases cardiovascular unfavourable outcomes in outpatients with heart failure. BMC Nephrol (2009) 0.86
Decreased body mass index as an independent risk factor for developing chronic kidney disease. Clin Exp Nephrol (2008) 0.85
Relation of low glomerular filtration rate to metabolic disorders in individuals without diabetes and with normoalbuminuria. Clin J Am Soc Nephrol (2008) 0.85
The Association between Parathyroid Hormone Levels and the Cardiorenal Metabolic Syndrome in Non-Diabetic Chronic Kidney Disease. Cardiorenal Med (2011) 0.85
Association between noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver disease. PLoS One (2014) 0.85
Metabolic syndrome, insulin resistance and kidney function in non-diabetic individuals. Nephrol Dial Transplant (2011) 0.85
Sex difference in the association of metabolic syndrome with high sensitivity C-reactive protein in a Taiwanese population. BMC Public Health (2010) 0.85
Relationship between chronic kidney disease and metabolic syndrome: current perspectives. Diabetes Metab Syndr Obes (2014) 0.85
Association between Metabolic Syndrome and Microalbuminuria in Korean Adults. Korean J Fam Med (2015) 0.85
Lifestyle factors and indices of kidney function in the Framingham Heart Study. Am J Nephrol (2015) 0.84
Metabolic syndrome and nephrolithiasis: can we hypotize a common background? Clin Cases Miner Bone Metab (2008) 0.84
The association of chronic kidney disease and metabolic syndrome with incident cardiovascular events: multiethnic study of atherosclerosis. Cardiol Res Pract (2011) 0.84
Association of inflammation and endothelial dysfunction with metabolic syndrome, prediabetes and diabetes in adults from Inner Mongolia, China. BMC Endocr Disord (2011) 0.84
The association between individual and combined components of metabolic syndrome and chronic kidney disease among African Americans: the Jackson Heart Study. PLoS One (2014) 0.83
Metabolic syndrome and risk of progression of chronic kidney disease: a single-center cohort study in Japan. Heart Vessels (2012) 0.83
Tobacco and metabolic syndrome. Indian J Endocrinol Metab (2012) 0.83
Diet-induced obesity and kidney disease - In search of a susceptible mouse model. Biochimie (2015) 0.83
Kidney function in obese adolescents with or without metabolic syndrome in a nationally-representative sample of pediatric population: First report from the Middle East and North Africa: The CASPIAN-III Study: A Case-Control Study. J Res Med Sci (2013) 0.83
Association of the Q121 variant of ENPP1 gene with decreased kidney function among patients with type 2 diabetes. Am J Kidney Dis (2008) 0.83
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78
Global burden of hypertension: analysis of worldwide data. Lancet (2005) 32.76
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74
Prevalence of diabetes among men and women in China. N Engl J Med (2010) 19.98
A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med (2015) 19.14
Major causes of death among men and women in China. N Engl J Med (2005) 11.80
Prevalence and control of diabetes in Chinese adults. JAMA (2013) 11.73
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14
The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med (2008) 9.95
Mortality prediction with a single general self-rated health question. A meta-analysis. J Gen Intern Med (2005) 8.95
Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA (2002) 7.93
The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol (2003) 7.79
Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med (2011) 6.89
Worldwide prevalence of hypertension: a systematic review. J Hypertens (2004) 6.25
Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med (2002) 5.92
Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA (2011) 5.86
Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 5.46
Effects of low-carbohydrate and low-fat diets: a randomized trial. Ann Intern Med (2014) 5.31
Prevalence of the metabolic syndrome and overweight among adults in China. Lancet (2005) 5.05
APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med (2013) 5.00
Mortality attributable to smoking in China. N Engl J Med (2009) 4.75
Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med (2006) 4.69
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation (2006) 4.61
Fast, three-dimensional super-resolution imaging of live cells. Nat Methods (2011) 4.52
Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 4.38
Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study. Ethn Dis (2005) 4.32
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care (2007) 4.30
Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet (2012) 4.25
Systematic review: glucose control and cardiovascular disease in type 2 diabetes. Ann Intern Med (2009) 4.19
Prevalence, awareness, treatment, and control of hypertension in china. Hypertension (2002) 4.18
Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol (2009) 4.16
Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis. JAMA (2011) 4.09
Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat Genet (2011) 4.04
Trends in blood pressure among children and adolescents. JAMA (2004) 4.03
Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Am J Clin Nutr (2002) 4.00
Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol (2002) 3.92
Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA (2005) 3.89
Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med (2002) 3.77
New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care (2009) 3.73
Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004. Pediatrics (2009) 3.62
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann Intern Med (2010) 3.56
Alcohol consumption and risk of stroke: a meta-analysis. JAMA (2003) 3.54
Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study. Ann Intern Med (2011) 3.49
Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults. Circulation (2006) 3.47
Body weight and mortality among men and women in China. JAMA (2006) 3.41
Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA (2006) 3.39
Lower levels of sodium intake and reduced cardiovascular risk. Circulation (2014) 3.39
Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003. Circulation (2003) 3.22
Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines. Ann Pharmacother (2008) 3.20
Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA (2004) 3.20
Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. Hypertension (2003) 3.18
Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation (2012) 3.14
Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring. Diabetes Care (2003) 3.08
Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Diabetes Care (2004) 3.00
Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol (2004) 3.00
Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension (2007) 2.98
The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med (2004) 2.94
Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol (2004) 2.91
Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2016) 2.87
Blood pressure measurement device, number and timing of visits, and intra-individual visit-to-visit variability of blood pressure. J Clin Hypertens (Greenwich) (2012) 2.85
Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort. Hypertension (2013) 2.83
Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up study. Arch Intern Med (2009) 2.81
Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Ann Intern Med (2006) 2.81
Effect of soybean protein on blood pressure: a randomized, controlled trial. Ann Intern Med (2005) 2.79
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study. Lancet (2009) 2.73
Meta-analysis identifies common variants associated with body mass index in east Asians. Nat Genet (2012) 2.70
Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china. Circ Cardiovasc Qual Outcomes (2010) 2.63